Max Healthcare Institute Limited (Symbol: MAXHEALTH, Scrip Code: 543220) has submitted a regulatory disclosure to the National Stock Exchange of India Limited and BSE Limited regarding ongoing legal proceedings involving its subsidiary, Kalinga Hospital Ltd (KHL).
This disclosure is made under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and serves as a continuation of the company's earlier intimation dated September 29, 2026.
The matter involves petitions, including interlocutory petitions, filed before the Hon'ble National Company Law Tribunal (NCLT), Cuttack Bench by the legal representatives of BRS Capital Two Pte. Limited. The petitions are against Kalinga Hospital Ltd (a subsidiary of Max Healthcare), the other shareholder of KHL from whom Max Healthcare acquired the majority equity stake, and Max Healthcare itself.
The petitions were listed for hearing on October 29, 2026 at 2:30 pm (IST). However, the matter could not be heard by the Hon'ble NCLT, Cuttack Bench due to paucity of time. The Hon'ble NCLT has adjourned the matter to October 30, 2026 for further hearing.
The disclosure confirms that sections regarding litigation against key management personnel/promoters and settlement of proceedings are not applicable to this matter. The company will host this disclosure on its website at www.maxhealthcare.in.
The communication was signed by Dhiraj Aroraa, EVP - Company Secretary and Compliance Officer of Max Healthcare.